BSc MSc PhD
Albert Jan van Hoek (Dutch) is an assistant professor in Vaccine Economics. He is a biologist by training but obtained a PhD in cost-effectiveness modelling of vaccination programmes. Cost-effectiveness modelling of vaccination programmes is a multi-diciplinairy specialisation which spans the fields of health economics, infectious disease epidemiology and infectious disease transmission modelling. The combination offers the best of these three fields.
Before joining the school he worked for 7+ years in the modelling unit and immunisation department of Public Health England (PHE, also called Health Protection Agency before), the public health body for England and his work informed and guided national decision making. The main pathogens he worked on were: varicella zoster, influenza, streptococcus pneumoniae and bordetella pertussis. Apart from disease specific studies he also performed work on the assessment of the quality of life and collected information on contact patterns. During his time at PHE he was seconded twice to a reasearch institute on the African continent; once to the MRC in the Gambia (two months) and once to KEMRI in Kenia (three months).
At the school Albert is employed by the immunisation HPRU. This HPRU is a formal collaboration between LSHTM and PHE. With his move from PHE to LSHTM he thererfore did not move far from his old job, and his work remains focussed on performing research to underpin and enhance vaccination policy in England. His projects at the moment are focussed on equity and vaccination programmes, the costs of vaccination and measuring the utility of prevented disease burden.
He is still involved in projects at Public Health England, supervising work on varicella, pneumococcal disease and HIV and he is a co-leader on a workpackage of the I-MOVE+ project.
Beside his work at the school Albert advices sub-committees on pneumococcus and varicella linked to the Joint Committee for Vaccination and Immunisation (JCVI) and is a member of the vaccination committee of the Dutch health council.